Literature DB >> 2898953

Molecular genetic analysis of porcine von Willebrand disease: tight linkage to the von Willebrand factor locus.

W F Bahou1, E J Bowie, D N Fass, D Ginsburg.   

Abstract

von Willebrand disease (vWD), one of the most common bleeding disorders in humans, is manifested as a quantitative or qualitative defect in von Willebrand factor (vWF), an adhesive glycoprotein (GP) with critical hemostatic functions. Except for the rare severely affected patient with a gene deletion as etiology of the disease, the molecular basis for vWD is not known. We studied the molecular basis for vWD in a breeding colony of pigs with a disease closely resembling the human disorder. The porcine vWF gene is similar in size and complexity to its human counterpart, and no gross gene deletion or rearrangement was evident as the pathogenesis of porcine vWD. A restriction fragment-length polymorphism (RFLP) within the porcine vWF gene was identified with the restriction endonuclease HindIII, and 22/35 members of the pedigree were analyzed for the polymorphic site. Linkage between the vWF locus and the vWD phenotype was established with a calculated LOD score of 5.3 (1/200,000 probability by chance alone), with no crossovers identified. These findings indicate that porcine vWD is due to a molecular defect within (or near) the vWF locus, most likely representing a point mutation or small insertion/deletion within the vWF gene.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898953

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIB von Willebrand disease.

Authors:  E W Murray; A R Giles; D Lillicrap
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

2.  The localization of the von Willebrand factor gene on cattle, sheep and goat chromosomes illustrates karyotype evolution in mammals.

Authors:  N Janel; L Schibler; A Oustry; D Kerbiriou-Nabias; E P Cribiu; D Vaiman
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

3.  Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.

Authors:  D Ginsburg; B A Konkle; J C Gill; R R Montgomery; P L Bockenstedt; T A Johnson; A Y Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 4.  Animal models of hemophilia and related bleeding disorders.

Authors:  Jay N Lozier; Timothy C Nichols
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

5.  Mammalian COPII coat component SEC24C is required for embryonic development in mice.

Authors:  Elizabeth J Adams; Xiao-Wei Chen; K Sue O'Shea; David Ginsburg
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

6.  Porcine and canine von Willebrand factor and von Willebrand disease: hemostasis, thrombosis, and atherosclerosis studies.

Authors:  Timothy C Nichols; Dwight A Bellinger; Elizabeth P Merricks; Robin A Raymer; Mark T Kloos; Natalie Defriess; Margaret V Ragni; Thomas R Griggs
Journal:  Thrombosis       Date:  2011-02-07

7.  A 12.3-kb Duplication Within the VWF Gene in Pigs Affected by Von Willebrand Disease Type 3.

Authors:  Stefanie Lehner; Mahnaz Ekhlasi-Hundrieser; Carsten Detering; Hanna Allerkamp; Christiane Pfarrer; Mario von Depka Prondzinski
Journal:  G3 (Bethesda)       Date:  2018-02-02       Impact factor: 3.154

8.  Disruption of the Sec24d gene results in early embryonic lethality in the mouse.

Authors:  Andrea C Baines; Elizabeth J Adams; Bin Zhang; David Ginsburg
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

9.  The endothelial-specific regulatory mutation, Mvwf1, is a common mouse founder allele.

Authors:  Jill M Johnsen; Gallia G Levy; Randal J Westrick; Priscilla K Tucker; David Ginsburg
Journal:  Mamm Genome       Date:  2008-01-11       Impact factor: 2.957

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.